Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds

cancer

  • You have access
    Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical Therapy
    Hossein Jadvar and Patrick M. Colletti
    Journal of Nuclear Medicine Technology March 1, 2023, 51 (1) 16-21; DOI: https://doi.org/10.2967/jnmt.122.264928
  • You have access
    Biology of Cancer and PET Imaging: Pictorial Review
    Ismet Sarikaya
    Journal of Nuclear Medicine Technology June 1, 2022, 50 (2) 81-89; DOI: https://doi.org/10.2967/jnmt.121.263534
  • You have access
    Administration of Subcutaneous Buffered Lidocaine Prior to Breast Lymphoscintigraphy Reduces Pain Without Decreasing Lymph Node Visualization
    Andrew S. Hawkins, Don C. Yoo, Jonathan S. Movson, Richard B. Noto, Kelly Powers and Grayson L. Baird
    Journal of Nuclear Medicine Technology December 1, 2014, 42 (4) 260-264; DOI: https://doi.org/10.2967/jnmt.114.144402
  • You have access
    Radiopharmaceuticals for Bone Malignancy Therapy
    Harold L. Atkins and Suresh C. Srivastava
    Journal of Nuclear Medicine Technology June 1, 1998, 26 (2) 80-83;
  • You have access
    Cancer Imaging with Radiolabeled Antibodies: New Advances with Technetium-99m-Labeled Monoclonal Antibody Fab’ Fragments, Especially CEA-Scan® and Prospects for Therapy
    David M. Goldenberg, Malik Juweid, Robert M. Dunn and Robert M. Sharkey
    Journal of Nuclear Medicine Technology March 1, 1997, 25 (1) 18-23;
SNMMI

© 2025 SNMMI

Powered by HighWire